Severance Alyscia Cory, Sandoval Philip J, Wright Stephen H
Department of Physiology, College of Medicine, University of Arizona, Tucson, Arizona.
Department of Physiology, College of Medicine, University of Arizona, Tucson, Arizona
J Pharmacol Exp Ther. 2017 Sep;362(3):405-412. doi: 10.1124/jpet.117.242552. Epub 2017 Jun 14.
Organic cation (OC) transporter 2 (OCT2) mediates the first step in the renal secretion of many cationic drugs: basolateral uptake from blood into proximal tubule cells. The impact of this process on the pharmacokinetics of drug clearance as estimated using a physiologically-based pharmacokinetic approach relies on an accurate understanding of the kinetics of transport because the ratio of the maximal rate of transport to the Michaelis constant (i.e., J/ K) provides an estimate of the intrinsic clearance (Cl) used in in vitro-in vivo extrapolation of experimentally determined transport data. Although the multispecificity of renal OC secretion, including that of the OCT2 transporter, is widely acknowledged, the possible relationship between relative affinity of the transporter for its diverse substrates and the maximal rates of their transport has received little attention. In this study, we determined the J and apparent Michaelis constant (K) values for six structurally distinct OCT2 substrates and found a strong correlation between J and K; high-affinity substrates [K values <50 M, including 1-methyl-4-phenylpyridinium, or 1-methyl-4-phenylpyridinium (MPP), and cimetidine] displayed systematically lower J values (<50 pmol cm min) than did low-affinity substrates (K >200 M, including choline and metformin). Similarly, preloading OCT2-expressing cells with low-affinity substrates resulted in systematically larger -stimulated rates of MPP uptake than did preloading with high-affinity substrates. The data are quantitatively consistent with the hypothesis that dissociation of bound substrate from the transporter is rate limiting in establishing maximal rates of OCT2-mediated transport. This systematic relationship may provide a means to estimate Cl for drugs for which transport data are lacking.
有机阳离子(OC)转运体2(OCT2)介导了许多阳离子药物经肾脏分泌的第一步:从血液经基底外侧摄取进入近端肾小管细胞。使用基于生理学的药代动力学方法估算该过程对药物清除药代动力学的影响,依赖于对转运动力学的准确理解,因为转运最大速率与米氏常数的比值(即J/K)可用于估算体外-体内外推实验测定的转运数据时所使用的内在清除率(Cl)。尽管包括OCT2转运体在内的肾脏OC分泌的多特异性已得到广泛认可,但转运体对其多种底物的相对亲和力与它们的最大转运速率之间的可能关系却很少受到关注。在本研究中,我们测定了六种结构不同的OCT2底物的J值和表观米氏常数(K),发现J与K之间存在强相关性;高亲和力底物[K值<50 μM,包括1-甲基-4-苯基吡啶鎓或1-甲基-4-苯基吡啶鎓(MPP)和西咪替丁]的J值(<50 pmol·cm⁻²·min⁻¹)系统地低于低亲和力底物(K>200 μM,包括胆碱和二甲双胍)。同样,用低亲和力底物预加载表达OCT2的细胞,导致MPP摄取的刺激速率比用高亲和力底物预加载时系统地更大。这些数据在定量上与以下假设一致,即结合底物从转运体上解离是建立OCT2介导的最大转运速率的限速步骤。这种系统关系可能为估算缺乏转运数据的药物的Cl提供一种方法。